1 Report Business Overview
1.1 Study Scope
1.2 Market Analysis by Type
1.2.1 Global Chronic Liver Diseases Therapeutics Market Size Growth Rate by Type, 2017 VS 2021 VS 2028
1.2.2 Chemotherapy Drugs
1.2.3 Targeted Therapy
1.2.4 Vaccines
1.2.5 Antiviral Drugs
1.2.6 Immunoglobulins
1.2.7 Corticosteroids
1.2.8 Others
1.3 Market by Application
1.3.1 Global Chronic Liver Diseases Therapeutics Market Size Growth Rate by Application, 2017 VS 2021 VS 2028
1.3.2 Hospital Pharmacies
1.3.3 Retail Pharmacies
1.3.4 Online Pharmacies
1.4 Study Objectives
1.5 Years Considered
2 Global Growth Trends
2.1 Global Chronic Liver Diseases Therapeutics Market Perspective (2017-2028)
2.2 Chronic Liver Diseases Therapeutics Growth Trends by Region
2.2.1 Chronic Liver Diseases Therapeutics Market Size by Region: 2017 VS 2021 VS 2028
2.2.2 Chronic Liver Diseases Therapeutics Historic Market Size by Region (2017-2022)
2.2.3 Chronic Liver Diseases Therapeutics Forecasted Market Size by Region (2023-2028)
2.3 Chronic Liver Diseases Therapeutics Market Dynamics
2.3.1 Chronic Liver Diseases Therapeutics Industry Trends
2.3.2 Chronic Liver Diseases Therapeutics Market Drivers
2.3.3 Chronic Liver Diseases Therapeutics Market Challenges
2.3.4 Chronic Liver Diseases Therapeutics Market Restraints
3 Competition Landscape by Key Players
3.1 Global Top Chronic Liver Diseases Therapeutics Players by Revenue
3.1.1 Global Top Chronic Liver Diseases Therapeutics Players by Revenue (2017-2022)
3.1.2 Global Chronic Liver Diseases Therapeutics Revenue Market Share by Players (2017-2022)
3.2 Global Chronic Liver Diseases Therapeutics Market Share by Company Type (Tier 1, Tier 2, and Tier 3)
3.3 Players Covered: Ranking by Chronic Liver Diseases Therapeutics Revenue
3.4 Global Chronic Liver Diseases Therapeutics Market Concentration Ratio
3.4.1 Global Chronic Liver Diseases Therapeutics Market Concentration Ratio (CR5 and HHI)
3.4.2 Global Top 10 and Top 5 Companies by Chronic Liver Diseases Therapeutics Revenue in 2021
3.5 Chronic Liver Diseases Therapeutics Key Players Head office and Area Served
3.6 Key Players Chronic Liver Diseases Therapeutics Product Solution and Service
3.7 Date of Enter into Chronic Liver Diseases Therapeutics Market
3.8 Mergers & Acquisitions, Expansion Plans
4 Chronic Liver Diseases Therapeutics Breakdown Data by Type
4.1 Global Chronic Liver Diseases Therapeutics Historic Market Size by Type (2017-2022)
4.2 Global Chronic Liver Diseases Therapeutics Forecasted Market Size by Type (2023-2028)
5 Chronic Liver Diseases Therapeutics Breakdown Data by Application
5.1 Global Chronic Liver Diseases Therapeutics Historic Market Size by Application (2017-2022)
5.2 Global Chronic Liver Diseases Therapeutics Forecasted Market Size by Application (2023-2028)
6 North America
6.1 North America Chronic Liver Diseases Therapeutics Market Size (2017-2028)
6.2 North America Chronic Liver Diseases Therapeutics Market Size by Type
6.2.1 North America Chronic Liver Diseases Therapeutics Market Size by Type (2017-2022)
6.2.2 North America Chronic Liver Diseases Therapeutics Market Size by Type (2023-2028)
6.2.3 North America Chronic Liver Diseases Therapeutics Market Share by Type (2017-2028)
6.3 North America Chronic Liver Diseases Therapeutics Market Size by Application
6.3.1 North America Chronic Liver Diseases Therapeutics Market Size by Application (2017-2022)
6.3.2 North America Chronic Liver Diseases Therapeutics Market Size by Application (2023-2028)
6.3.3 North America Chronic Liver Diseases Therapeutics Market Share by Application (2017-2028)
6.4 North America Chronic Liver Diseases Therapeutics Market Size by Country
6.4.1 North America Chronic Liver Diseases Therapeutics Market Size by Country (2017-2022)
6.4.2 North America Chronic Liver Diseases Therapeutics Market Size by Country (2023-2028)
6.4.3 U.S.
6.4.4 Canada
7 Europe
7.1 Europe Chronic Liver Diseases Therapeutics Market Size (2017-2028)
7.2 Europe Chronic Liver Diseases Therapeutics Market Size by Type
7.2.1 Europe Chronic Liver Diseases Therapeutics Market Size by Type (2017-2022)
7.2.2 Europe Chronic Liver Diseases Therapeutics Market Size by Type (2023-2028)
7.2.3 Europe Chronic Liver Diseases Therapeutics Market Share by Type (2017-2028)
7.3 Europe Chronic Liver Diseases Therapeutics Market Size by Application
7.3.1 Europe Chronic Liver Diseases Therapeutics Market Size by Application (2017-2022)
7.3.2 Europe Chronic Liver Diseases Therapeutics Market Size by Application (2023-2028)
7.3.3 Europe Chronic Liver Diseases Therapeutics Market Share by Application (2017-2028)
7.4 Europe Chronic Liver Diseases Therapeutics Market Size by Country
7.4.1 Europe Chronic Liver Diseases Therapeutics Market Size by Country (2017-2022)
7.4.2 Europe Chronic Liver Diseases Therapeutics Market Size by Country (2023-2028)
7.4.3 Germany
7.4.4 France
7.4.5 U.K.
7.4.6 Italy
7.4.7 Russia
7.4.8 Nordic Countries
8 Asia-Pacific
8.1 Asia-Pacific Chronic Liver Diseases Therapeutics Market Size (2017-2028)
8.2 Asia-Pacific Chronic Liver Diseases Therapeutics Market Size by Type
8.2.1 Asia-Pacific Chronic Liver Diseases Therapeutics Market Size by Type (2017-2022)
8.2.2 Asia-Pacific Chronic Liver Diseases Therapeutics Market Size by Type (2023-2028)
8.2.3 Asia-Pacific Chronic Liver Diseases Therapeutics Market Share by Type (2017-2028)
8.3 Asia-Pacific Chronic Liver Diseases Therapeutics Market Size by Application
8.3.1 Asia-Pacific Chronic Liver Diseases Therapeutics Market Size by Application (2017-2022)
8.3.2 Asia-Pacific Chronic Liver Diseases Therapeutics Market Size by Application (2023-2028)
8.3.3 Asia-Pacific Chronic Liver Diseases Therapeutics Market Share by Application (2017-2028)
8.4 Asia-Pacific Chronic Liver Diseases Therapeutics Market Size by Region
8.4.1 Asia-Pacific Chronic Liver Diseases Therapeutics Market Size by Region (2017-2022)
8.4.2 Asia-Pacific Chronic Liver Diseases Therapeutics Market Size by Region (2023-2028)
8.4.3 China
8.4.4 Japan
8.4.5 South Korea
8.4.6 Southeast Asia
8.4.7 India
8.4.8 Australia
9 Latin America
9.1 Latin America Chronic Liver Diseases Therapeutics Market Size (2017-2028)
9.2 Latin America Chronic Liver Diseases Therapeutics Market Size by Type
9.2.1 Latin America Chronic Liver Diseases Therapeutics Market Size by Type (2017-2022)
9.2.2 Latin America Chronic Liver Diseases Therapeutics Market Size by Type (2023-2028)
9.2.3 Latin America Chronic Liver Diseases Therapeutics Market Share by Type (2017-2028)
9.3 Latin America Chronic Liver Diseases Therapeutics Market Size by Application
9.3.1 Latin America Chronic Liver Diseases Therapeutics Market Size by Application (2017-2022)
9.3.2 Latin America Chronic Liver Diseases Therapeutics Market Size by Application (2023-2028)
9.3.3 Latin America Chronic Liver Diseases Therapeutics Market Share by Application (2017-2028)
9.4 Latin America Chronic Liver Diseases Therapeutics Market Size by Country
9.4.1 Latin America Chronic Liver Diseases Therapeutics Market Size by Country (2017-2022)
9.4.2 Latin America Chronic Liver Diseases Therapeutics Market Size by Country (2023-2028)
9.4.3 Mexico
9.4.4 Brazil
10 Middle East & Africa
10.1 Middle East & Africa Chronic Liver Diseases Therapeutics Market Size (2017-2028)
10.2 Middle East & Africa Chronic Liver Diseases Therapeutics Market Size by Type
10.2.1 Middle East & Africa Chronic Liver Diseases Therapeutics Market Size by Type (2017-2022)
10.2.2 Middle East & Africa Chronic Liver Diseases Therapeutics Market Size by Type (2023-2028)
10.2.3 Middle East & Africa Chronic Liver Diseases Therapeutics Market Share by Type (2017-2028)
10.3 Middle East & Africa Chronic Liver Diseases Therapeutics Market Size by Application
10.3.1 Middle East & Africa Chronic Liver Diseases Therapeutics Market Size by Application (2017-2022)
10.3.2 Middle East & Africa Chronic Liver Diseases Therapeutics Market Size by Application (2023-2028)
10.3.3 Middle East & Africa Chronic Liver Diseases Therapeutics Market Share by Application (2017-2028)
10.4 Middle East & Africa Chronic Liver Diseases Therapeutics Market Size by Country
10.4.1 Middle East & Africa Chronic Liver Diseases Therapeutics Market Size by Country (2017-2022)
10.4.2 Middle East & Africa Chronic Liver Diseases Therapeutics Market Size by Country (2023-2028)
10.4.3 Turkey
10.4.4 Saudi Arabia
10.4.5 UAE
11 Key Players Profiles
11.1 Astellas Pharma
11.1.1 Astellas Pharma Company Details
11.1.2 Astellas Pharma Business Overview
11.1.3 Astellas Pharma Chronic Liver Diseases Therapeutics Introduction
11.1.4 Astellas Pharma Revenue in Chronic Liver Diseases Therapeutics Business (2017-2022)
11.1.5 Astellas Pharma Recent Developments
11.2 Bristol-Myers Squibb
11.2.1 Bristol-Myers Squibb Company Details
11.2.2 Bristol-Myers Squibb Business Overview
11.2.3 Bristol-Myers Squibb Chronic Liver Diseases Therapeutics Introduction
11.2.4 Bristol-Myers Squibb Revenue in Chronic Liver Diseases Therapeutics Business (2017-2022)
11.2.5 Bristol-Myers Squibb Recent Developments
11.3 Gilead Sciences
11.3.1 Gilead Sciences Company Details
11.3.2 Gilead Sciences Business Overview
11.3.3 Gilead Sciences Chronic Liver Diseases Therapeutics Introduction
11.3.4 Gilead Sciences Revenue in Chronic Liver Diseases Therapeutics Business (2017-2022)
11.3.5 Gilead Sciences Recent Developments
11.4 GlaxoSmithKline
11.4.1 GlaxoSmithKline Company Details
11.4.2 GlaxoSmithKline Business Overview
11.4.3 GlaxoSmithKline Chronic Liver Diseases Therapeutics Introduction
11.4.4 GlaxoSmithKline Revenue in Chronic Liver Diseases Therapeutics Business (2017-2022)
11.4.5 GlaxoSmithKline Recent Developments
11.5 F. Hoffmann-La Roche
11.5.1 F. Hoffmann-La Roche Company Details
11.5.2 F. Hoffmann-La Roche Business Overview
11.5.3 F. Hoffmann-La Roche Chronic Liver Diseases Therapeutics Introduction
11.5.4 F. Hoffmann-La Roche Revenue in Chronic Liver Diseases Therapeutics Business (2017-2022)
11.5.5 F. Hoffmann-La Roche Recent Developments
11.6 Merck
11.6.1 Merck Company Details
11.6.2 Merck Business Overview
11.6.3 Merck Chronic Liver Diseases Therapeutics Introduction
11.6.4 Merck Revenue in Chronic Liver Diseases Therapeutics Business (2017-2022)
11.6.5 Merck Recent Developments
11.7 Novartis
11.7.1 Novartis Company Details
11.7.2 Novartis Business Overview
11.7.3 Novartis Chronic Liver Diseases Therapeutics Introduction
11.7.4 Novartis Revenue in Chronic Liver Diseases Therapeutics Business (2017-2022)
11.7.5 Novartis Recent Developments
11.8 Sanofi
11.8.1 Sanofi Company Details
11.8.2 Sanofi Business Overview
11.8.3 Sanofi Chronic Liver Diseases Therapeutics Introduction
11.8.4 Sanofi Revenue in Chronic Liver Diseases Therapeutics Business (2017-2022)
11.8.5 Sanofi Recent Developments
11.9 Pfizer
11.9.1 Pfizer Company Details
11.9.2 Pfizer Business Overview
11.9.3 Pfizer Chronic Liver Diseases Therapeutics Introduction
11.9.4 Pfizer Revenue in Chronic Liver Diseases Therapeutics Business (2017-2022)
11.9.5 Pfizer Recent Developments
11.10 Takeda Pharmaceutical
11.10.1 Takeda Pharmaceutical Company Details
11.10.2 Takeda Pharmaceutical Business Overview
11.10.3 Takeda Pharmaceutical Chronic Liver Diseases Therapeutics Introduction
11.10.4 Takeda Pharmaceutical Revenue in Chronic Liver Diseases Therapeutics Business (2017-2022)
11.10.5 Takeda Pharmaceutical Recent Developments
11.11 Bausch Health
11.11.1 Bausch Health Company Details
11.11.2 Bausch Health Business Overview
11.11.3 Bausch Health Chronic Liver Diseases Therapeutics Introduction
11.11.4 Bausch Health Revenue in Chronic Liver Diseases Therapeutics Business (2017-2022)
11.11.5 Bausch Health Recent Developments
11.12 Theratechnologies
11.12.1 Theratechnologies Company Details
11.12.2 Theratechnologies Business Overview
11.12.3 Theratechnologies Chronic Liver Diseases Therapeutics Introduction
11.12.4 Theratechnologies Revenue in Chronic Liver Diseases Therapeutics Business (2017-2022)
11.12.5 Theratechnologies Recent Developments
11.13 Alnylam Pharmaceuticals
11.13.1 Alnylam Pharmaceuticals Company Details
11.13.2 Alnylam Pharmaceuticals Business Overview
11.13.3 Alnylam Pharmaceuticals Chronic Liver Diseases Therapeutics Introduction
11.13.4 Alnylam Pharmaceuticals Revenue in Chronic Liver Diseases Therapeutics Business (2017-2022)
11.13.5 Alnylam Pharmaceuticals Recent Developments
11.14 Protagonist Therapeutics
11.14.1 Protagonist Therapeutics Company Details
11.14.2 Protagonist Therapeutics Business Overview
11.14.3 Protagonist Therapeutics Chronic Liver Diseases Therapeutics Introduction
11.14.4 Protagonist Therapeutics Revenue in Chronic Liver Diseases Therapeutics Business (2017-2022)
11.14.5 Protagonist Therapeutics Recent Developments
11.15 Dicerna Pharmaceuticals
11.15.1 Dicerna Pharmaceuticals Company Details
11.15.2 Dicerna Pharmaceuticals Business Overview
11.15.3 Dicerna Pharmaceuticals Chronic Liver Diseases Therapeutics Introduction
11.15.4 Dicerna Pharmaceuticals Revenue in Chronic Liver Diseases Therapeutics Business (2017-2022)
11.15.5 Dicerna Pharmaceuticals Recent Developments
11.16 Endo International
11.16.1 Endo International Company Details
11.16.2 Endo International Business Overview
11.16.3 Endo International Chronic Liver Diseases Therapeutics Introduction
11.16.4 Endo International Revenue in Chronic Liver Diseases Therapeutics Business (2017-2022)
11.16.5 Endo International Recent Developments
11.17 Provectus Biopharmaceuticals
11.17.1 Provectus Biopharmaceuticals Company Details
11.17.2 Provectus Biopharmaceuticals Business Overview
11.17.3 Provectus Biopharmaceuticals Chronic Liver Diseases Therapeutics Introduction
11.17.4 Provectus Biopharmaceuticals Revenue in Chronic Liver Diseases Therapeutics Business (2017-2022)
11.17.5 Provectus Biopharmaceuticals Recent Developments
11.18 MAX BioPharma
11.18.1 MAX BioPharma Company Details
11.18.2 MAX BioPharma Business Overview
11.18.3 MAX BioPharma Chronic Liver Diseases Therapeutics Introduction
11.18.4 MAX BioPharma Revenue in Chronic Liver Diseases Therapeutics Business (2017-2022)
11.18.5 MAX BioPharma Recent Developments
12 Analyst's Viewpoints/Conclusions
13 Appendix
13.1 Research Methodology
13.1.1 Methodology/Research Approach
13.1.2 Data Source
13.2 Author Details
13.3 Disclaimer
List of Tables
Table 1. Global Chronic Liver Diseases Therapeutics Market Size Growth Rate by Type (US$ Million), 2017 VS 2021 VS 2028
Table 2. Key Players of Chemotherapy Drugs
Table 3. Key Players of Targeted Therapy
Table 4. Key Players of Vaccines
Table 5. Key Players of Antiviral Drugs
Table 6. Key Players of Immunoglobulins
Table 7. Key Players of Corticosteroids
Table 8. Key Players of Others
Table 9. Global Chronic Liver Diseases Therapeutics Market Size Growth Rate by Application (US$ Million), 2017 VS 2021 VS 2028
Table 10. Global Chronic Liver Diseases Therapeutics Market Size by Region (US$ Million): 2017 VS 2021 VS 2028
Table 11. Global Chronic Liver Diseases Therapeutics Market Size by Region (2017-2022) & (US$ Million)
Table 12. Global Chronic Liver Diseases Therapeutics Market Share by Region (2017-2022)
Table 13. Global Chronic Liver Diseases Therapeutics Forecasted Market Size by Region (2023-2028) & (US$ Million)
Table 14. Global Chronic Liver Diseases Therapeutics Market Share by Region (2023-2028)
Table 15. Chronic Liver Diseases Therapeutics Market Trends
Table 16. Chronic Liver Diseases Therapeutics Market Drivers
Table 17. Chronic Liver Diseases Therapeutics Market Challenges
Table 18. Chronic Liver Diseases Therapeutics Market Restraints
Table 19. Global Chronic Liver Diseases Therapeutics Revenue by Players (2017-2022) & (US$ Million)
Table 20. Global Chronic Liver Diseases Therapeutics Revenue Share by Players (2017-2022)
Table 21. Global Top Chronic Liver Diseases Therapeutics by Company Type (Tier 1, Tier 2, and Tier 3) & (based on the Revenue in Chronic Liver Diseases Therapeutics as of 2021)
Table 22. Ranking of Global Top Chronic Liver Diseases Therapeutics Companies by Revenue (US$ Million) in 2021
Table 23. Global 5 Largest Players Market Share by Chronic Liver Diseases Therapeutics Revenue (CR5 and HHI) & (2017-2022)
Table 24. Key Players Headquarters and Area Served
Table 25. Key Players Chronic Liver Diseases Therapeutics Product Solution and Service
Table 26. Date of Enter into Chronic Liver Diseases Therapeutics Market
Table 27. Mergers & Acquisitions, Expansion Plans
Table 28. Global Chronic Liver Diseases Therapeutics Market Size by Type (2017-2022) & (US$ Million)
Table 29. Global Chronic Liver Diseases Therapeutics Revenue Market Share by Type (2017-2022)
Table 30. Global Chronic Liver Diseases Therapeutics Forecasted Market Size by Type (2023-2028) & (US$ Million)
Table 31. Global Chronic Liver Diseases Therapeutics Revenue Market Share by Type (2023-2028)
Table 32. Global Chronic Liver Diseases Therapeutics Market Size by Application (2017-2022) & (US$ Million)
Table 33. Global Chronic Liver Diseases Therapeutics Revenue Share by Application (2017-2022)
Table 34. Global Chronic Liver Diseases Therapeutics Forecasted Market Size by Application (2023-2028) & (US$ Million)
Table 35. Global Chronic Liver Diseases Therapeutics Revenue Share by Application (2023-2028)
Table 36. North America Chronic Liver Diseases Therapeutics Market Size by Type (2017-2022) & (US$ Million)
Table 37. North America Chronic Liver Diseases Therapeutics Market Size by Type (2023-2028) & (US$ Million)
Table 38. North America Chronic Liver Diseases Therapeutics Market Size by Application (2017-2022) & (US$ Million)
Table 39. North America Chronic Liver Diseases Therapeutics Market Size by Application (2023-2028) & (US$ Million)
Table 40. North America Chronic Liver Diseases Therapeutics Market Size by Country (2017-2022) & (US$ Million)
Table 41. North America Chronic Liver Diseases Therapeutics Market Size by Country (2023-2028) & (US$ Million)
Table 42. Europe Chronic Liver Diseases Therapeutics Market Size by Type (2017-2022) & (US$ Million)
Table 43. Europe Chronic Liver Diseases Therapeutics Market Size by Type (2023-2028) & (US$ Million)
Table 44. Europe Chronic Liver Diseases Therapeutics Market Size by Application (2017-2022) & (US$ Million)
Table 45. Europe Chronic Liver Diseases Therapeutics Market Size by Application (2023-2028) & (US$ Million)
Table 46. Europe Chronic Liver Diseases Therapeutics Market Size by Country (2017-2022) & (US$ Million)
Table 47. Europe Chronic Liver Diseases Therapeutics Market Size by Country (2023-2028) & (US$ Million)
Table 48. Asia Pacific Chronic Liver Diseases Therapeutics Market Size by Type (2017-2022) & (US$ Million)
Table 49. Asia Pacific Chronic Liver Diseases Therapeutics Market Size by Type (2023-2028) & (US$ Million)
Table 50. Asia Pacific Chronic Liver Diseases Therapeutics Market Size by Application (2017-2022) & (US$ Million)
Table 51. Asia Pacific Chronic Liver Diseases Therapeutics Market Size by Application (2023-2028) & (US$ Million)
Table 52. Asia Pacific Chronic Liver Diseases Therapeutics Market Size by Region (2017-2022) & (US$ Million)
Table 53. Asia Pacific Chronic Liver Diseases Therapeutics Market Size by Region (2023-2028) & (US$ Million)
Table 54. Latin America Chronic Liver Diseases Therapeutics Market Size by Type (2017-2022) & (US$ Million)
Table 55. Latin America Chronic Liver Diseases Therapeutics Market Size by Type (2023-2028) & (US$ Million)
Table 56. Latin America Chronic Liver Diseases Therapeutics Market Size by Application (2017-2022) & (US$ Million)
Table 57. Latin America Chronic Liver Diseases Therapeutics Market Size by Application (2023-2028) & (US$ Million)
Table 58. Latin America Chronic Liver Diseases Therapeutics Market Size by Country (2017-2022) & (US$ Million)
Table 59. Latin America Chronic Liver Diseases Therapeutics Market Size by Country (2023-2028) & (US$ Million)
Table 60. Middle East and Africa Chronic Liver Diseases Therapeutics Market Size by Type (2017-2022) & (US$ Million)
Table 61. Middle East and Africa Chronic Liver Diseases Therapeutics Market Size by Type (2023-2028) & (US$ Million)
Table 62. Middle East and Africa Chronic Liver Diseases Therapeutics Market Size by Application (2017-2022) & (US$ Million)
Table 63. Middle East and Africa Chronic Liver Diseases Therapeutics Market Size by Application (2023-2028) & (US$ Million)
Table 64. Middle East and Africa Chronic Liver Diseases Therapeutics Market Size by Country (2017-2022) & (US$ Million)
Table 65. Middle East and Africa Chronic Liver Diseases Therapeutics Market Size by Country (2023-2028) & (US$ Million)
Table 66. Astellas Pharma Company Details
Table 67. Astellas Pharma Business Overview
Table 68. Astellas Pharma Chronic Liver Diseases Therapeutics Product
Table 69. Astellas Pharma Revenue in Chronic Liver Diseases Therapeutics Business (2017-2022) & (US$ Million)
Table 70. Astellas Pharma Recent Developments
Table 71. Bristol-Myers Squibb Company Details
Table 72. Bristol-Myers Squibb Business Overview
Table 73. Bristol-Myers Squibb Chronic Liver Diseases Therapeutics Product
Table 74. Bristol-Myers Squibb Revenue in Chronic Liver Diseases Therapeutics Business (2017-2022) & (US$ Million)
Table 75. Bristol-Myers Squibb Recent Developments
Table 76. Gilead Sciences Company Details
Table 77. Gilead Sciences Business Overview
Table 78. Gilead Sciences Chronic Liver Diseases Therapeutics Product
Table 79. Gilead Sciences Revenue in Chronic Liver Diseases Therapeutics Business (2017-2022) & (US$ Million)
Table 80. Gilead Sciences Recent Developments
Table 81. GlaxoSmithKline Company Details
Table 82. GlaxoSmithKline Business Overview
Table 83. GlaxoSmithKline Chronic Liver Diseases Therapeutics Product
Table 84. GlaxoSmithKline Revenue in Chronic Liver Diseases Therapeutics Business (2017-2022) & (US$ Million)
Table 85. GlaxoSmithKline Recent Developments
Table 86. F. Hoffmann-La Roche Company Details
Table 87. F. Hoffmann-La Roche Business Overview
Table 88. F. Hoffmann-La Roche Chronic Liver Diseases Therapeutics Product
Table 89. F. Hoffmann-La Roche Revenue in Chronic Liver Diseases Therapeutics Business (2017-2022) & (US$ Million)
Table 90. F. Hoffmann-La Roche Recent Developments
Table 91. Merck Company Details
Table 92. Merck Business Overview
Table 93. Merck Chronic Liver Diseases Therapeutics Product
Table 94. Merck Revenue in Chronic Liver Diseases Therapeutics Business (2017-2022) & (US$ Million)
Table 95. Merck Recent Developments
Table 96. Novartis Company Details
Table 97. Novartis Business Overview
Table 98. Novartis Chronic Liver Diseases Therapeutics Product
Table 99. Novartis Revenue in Chronic Liver Diseases Therapeutics Business (2017-2022) & (US$ Million)
Table 100. Novartis Recent Developments
Table 101. Sanofi Company Details
Table 102. Sanofi Business Overview
Table 103. Sanofi Chronic Liver Diseases Therapeutics Product
Table 104. Sanofi Revenue in Chronic Liver Diseases Therapeutics Business (2017-2022) & (US$ Million)
Table 105. Sanofi Recent Developments
Table 106. Pfizer Company Details
Table 107. Pfizer Business Overview
Table 108. Pfizer Chronic Liver Diseases Therapeutics Product
Table 109. Pfizer Revenue in Chronic Liver Diseases Therapeutics Business (2017-2022) & (US$ Million)
Table 110. Pfizer Recent Developments
Table 111. Takeda Pharmaceutical Company Details
Table 112. Takeda Pharmaceutical Business Overview
Table 113. Takeda Pharmaceutical Chronic Liver Diseases Therapeutics Product
Table 114. Takeda Pharmaceutical Revenue in Chronic Liver Diseases Therapeutics Business (2017-2022) & (US$ Million)
Table 115. Takeda Pharmaceutical Recent Developments
Table 116. Bausch Health Company Details
Table 117. Bausch Health Business Overview
Table 118. Bausch Health Chronic Liver Diseases Therapeutics Product
Table 119. Bausch Health Revenue in Chronic Liver Diseases Therapeutics Business (2017-2022) & (US$ Million)
Table 120. Bausch Health Recent Developments
Table 121. Theratechnologies Company Details
Table 122. Theratechnologies Business Overview
Table 123. Theratechnologies Chronic Liver Diseases Therapeutics Product
Table 124. Theratechnologies Revenue in Chronic Liver Diseases Therapeutics Business (2017-2022) & (US$ Million)
Table 125. Theratechnologies Recent Developments
Table 126. Alnylam Pharmaceuticals Company Details
Table 127. Alnylam Pharmaceuticals Business Overview
Table 128. Alnylam Pharmaceuticals Chronic Liver Diseases Therapeutics Product
Table 129. Alnylam Pharmaceuticals Revenue in Chronic Liver Diseases Therapeutics Business (2017-2022) & (US$ Million)
Table 130. Alnylam Pharmaceuticals Recent Developments
Table 131. Protagonist Therapeutics Company Details
Table 132. Protagonist Therapeutics Business Overview
Table 133. Protagonist Therapeutics Chronic Liver Diseases Therapeutics Product
Table 134. Protagonist Therapeutics Revenue in Chronic Liver Diseases Therapeutics Business (2017-2022) & (US$ Million)
Table 135. Protagonist Therapeutics Recent Developments
Table 136. Dicerna Pharmaceuticals Company Details
Table 137. Dicerna Pharmaceuticals Business Overview
Table 138. Dicerna Pharmaceuticals Chronic Liver Diseases Therapeutics Product
Table 139. Dicerna Pharmaceuticals Revenue in Chronic Liver Diseases Therapeutics Business (2017-2022) & (US$ Million)
Table 140. Dicerna Pharmaceuticals Recent Developments
Table 141. Endo International Company Details
Table 142. Endo International Business Overview
Table 143. Endo International Chronic Liver Diseases Therapeutics Product
Table 144. Endo International Revenue in Chronic Liver Diseases Therapeutics Business (2017-2022) & (US$ Million)
Table 145. Endo International Recent Developments
Table 146. Provectus Biopharmaceuticals Company Details
Table 147. Provectus Biopharmaceuticals Business Overview
Table 148. Provectus Biopharmaceuticals Chronic Liver Diseases Therapeutics Product
Table 149. Provectus Biopharmaceuticals Revenue in Chronic Liver Diseases Therapeutics Business (2017-2022) & (US$ Million)
Table 150. Provectus Biopharmaceuticals Recent Developments
Table 151. MAX BioPharma Company Details
Table 152. MAX BioPharma Business Overview
Table 153. MAX BioPharma Chronic Liver Diseases Therapeutics Product
Table 154. MAX BioPharma Revenue in Chronic Liver Diseases Therapeutics Business (2017-2022) & (US$ Million)
Table 155. MAX BioPharma Recent Developments
Table 156. Research Programs/Design for This Report
Table 157. Key Data Information from Secondary Sources
Table 158. Key Data Information from Primary Sources
List of Figures
Figure 1. Global Chronic Liver Diseases Therapeutics Market Share by Type: 2021 VS 2028
Figure 2. Chemotherapy Drugs Features
Figure 3. Targeted Therapy Features
Figure 4. Vaccines Features
Figure 5. Antiviral Drugs Features
Figure 6. Immunoglobulins Features
Figure 7. Corticosteroids Features
Figure 8. Others Features
Figure 9. Global Chronic Liver Diseases Therapeutics Market Share by Application: 2021 VS 2028
Figure 10. Hospital Pharmacies Case Studies
Figure 11. Retail Pharmacies Case Studies
Figure 12. Online Pharmacies Case Studies
Figure 13. Chronic Liver Diseases Therapeutics Report Years Considered
Figure 14. Global Chronic Liver Diseases Therapeutics Market Size (US$ Million), Year-over-Year: 2017-2028
Figure 15. Global Chronic Liver Diseases Therapeutics Market Size, (US$ Million), 2017 VS 2021 VS 2028
Figure 16. Global Chronic Liver Diseases Therapeutics Market Share by Region: 2021 VS 2028
Figure 17. Global Chronic Liver Diseases Therapeutics Market Share by Players in 2021
Figure 18. Global Top Chronic Liver Diseases Therapeutics Players by Company Type (Tier 1, Tier 2, and Tier 3) & (based on the Revenue in Chronic Liver Diseases Therapeutics as of 2021)
Figure 19. The Top 10 and 5 Players Market Share by Chronic Liver Diseases Therapeutics Revenue in 2021
Figure 20. North America Chronic Liver Diseases Therapeutics Market Size YoY (2017-2028) & (US$ Million)
Figure 21. North America Chronic Liver Diseases Therapeutics Market Size Market Share by Type (2017-2028)
Figure 22. North America Chronic Liver Diseases Therapeutics Market Size Market Share by Application (2017-2028)
Figure 23. North America Chronic Liver Diseases Therapeutics Market Size Share by Country (2017-2028)
Figure 24. United States Chronic Liver Diseases Therapeutics Market Size YoY Growth (2017-2028) & (US$ Million)
Figure 25. Canada Chronic Liver Diseases Therapeutics Market Size YoY Growth (2017-2028) & (US$ Million)
Figure 26. Europe Chronic Liver Diseases Therapeutics Market Size YoY (2017-2028) & (US$ Million)
Figure 27. Europe Chronic Liver Diseases Therapeutics Market Size Market Share by Type (2017-2028)
Figure 28. Europe Chronic Liver Diseases Therapeutics Market Size Market Share by Application (2017-2028)
Figure 29. Europe Chronic Liver Diseases Therapeutics Market Size Share by Country (2017-2028)
Figure 30. Germany Chronic Liver Diseases Therapeutics Market Size YoY Growth (2017-2028) & (US$ Million)
Figure 31. France Chronic Liver Diseases Therapeutics Market Size YoY Growth (2017-2028) & (US$ Million)
Figure 32. U.K. Chronic Liver Diseases Therapeutics Market Size YoY Growth (2017-2028) & (US$ Million)
Figure 33. Italy Chronic Liver Diseases Therapeutics Market Size YoY Growth (2017-2028) & (US$ Million)
Figure 34. Russia Chronic Liver Diseases Therapeutics Market Size YoY Growth (2017-2028) & (US$ Million)
Figure 35. Nordic Countries Chronic Liver Diseases Therapeutics Market Size YoY Growth (2017-2028) & (US$ Million)
Figure 36. Asia-Pacific Chronic Liver Diseases Therapeutics Market Size YoY (2017-2028) & (US$ Million)
Figure 37. Asia Pacific Chronic Liver Diseases Therapeutics Market Size Market Share by Type (2017-2028)
Figure 38. Asia Pacific Chronic Liver Diseases Therapeutics Market Size Market Share by Application (2017-2028)
Figure 39. Asia Pacific Chronic Liver Diseases Therapeutics Market Size Share by Region (2017-2028)
Figure 40. China Chronic Liver Diseases Therapeutics Market Size YoY Growth (2017-2028) & (US$ Million)
Figure 41. Japan Chronic Liver Diseases Therapeutics Market Size YoY Growth (2017-2028) & (US$ Million)
Figure 42. South Korea Chronic Liver Diseases Therapeutics Market Size YoY Growth (2017-2028) & (US$ Million)
Figure 43. Southeast Asia Chronic Liver Diseases Therapeutics Market Size YoY Growth (2017-2028) & (US$ Million)
Figure 44. India Chronic Liver Diseases Therapeutics Market Size YoY Growth (2017-2028) & (US$ Million)
Figure 45. Australia Chronic Liver Diseases Therapeutics Market Size YoY Growth (2017-2028) & (US$ Million)
List of Figures
Figure 46. Latin America Chronic Liver Diseases Therapeutics Market Size YoY (2017-2028) & (US$ Million)
Figure 47. Latin America Chronic Liver Diseases Therapeutics Market Size Market Share by Type (2017-2028)
Figure 48. Latin America Chronic Liver Diseases Therapeutics Market Size Market Share by Application (2017-2028)
Figure 49. Latin America Chronic Liver Diseases Therapeutics Market Size Share by Country (2017-2028)
Figure 50. Mexico Chronic Liver Diseases Therapeutics Market Size YoY Growth (2017-2028) & (US$ Million)
Figure 51. Brazil Chronic Liver Diseases Therapeutics Market Size YoY Growth (2017-2028) & (US$ Million)
Figure 52. Middle East & Africa Chronic Liver Diseases Therapeutics Market Size YoY (2017-2028) & (US$ Million)
Figure 53. Middle East and Africa Chronic Liver Diseases Therapeutics Market Size Market Share by Type (2017-2028)
Figure 54. Middle East and Africa Chronic Liver Diseases Therapeutics Market Size Market Share by Application (2017-2028)
Figure 55. Middle East and Africa Chronic Liver Diseases Therapeutics Market Size Share by Country (2017-2028)
Figure 56. Turkey Chronic Liver Diseases Therapeutics Market Size YoY Growth (2017-2028) & (US$ Million)
Figure 57. Saudi Arabia Chronic Liver Diseases Therapeutics Market Size YoY Growth (2017-2028) & (US$ Million)
Figure 58. UAE Chronic Liver Diseases Therapeutics Market Size YoY Growth (2017-2028) & (US$ Million)
Figure 59. Astellas Pharma Revenue Growth Rate in Chronic Liver Diseases Therapeutics Business (2017-2022)
Figure 60. Bristol-Myers Squibb Revenue Growth Rate in Chronic Liver Diseases Therapeutics Business (2017-2022)
Figure 61. Gilead Sciences Revenue Growth Rate in Chronic Liver Diseases Therapeutics Business (2017-2022)
Figure 62. GlaxoSmithKline Revenue Growth Rate in Chronic Liver Diseases Therapeutics Business (2017-2022)
Figure 63. F. Hoffmann-La Roche Revenue Growth Rate in Chronic Liver Diseases Therapeutics Business (2017-2022)
Figure 64. Merck Revenue Growth Rate in Chronic Liver Diseases Therapeutics Business (2017-2022)
Figure 65. Novartis Revenue Growth Rate in Chronic Liver Diseases Therapeutics Business (2017-2022)
Figure 66. Sanofi Revenue Growth Rate in Chronic Liver Diseases Therapeutics Business (2017-2022)
Figure 67. Pfizer Revenue Growth Rate in Chronic Liver Diseases Therapeutics Business (2017-2022)
Figure 68. Takeda Pharmaceutical Revenue Growth Rate in Chronic Liver Diseases Therapeutics Business (2017-2022)
Figure 69. Bausch Health Revenue Growth Rate in Chronic Liver Diseases Therapeutics Business (2017-2022)
Figure 70. Theratechnologies Revenue Growth Rate in Chronic Liver Diseases Therapeutics Business (2017-2022)
Figure 71. Alnylam Pharmaceuticals Revenue Growth Rate in Chronic Liver Diseases Therapeutics Business (2017-2022)
Figure 72. Protagonist Therapeutics Revenue Growth Rate in Chronic Liver Diseases Therapeutics Business (2017-2022)
Figure 73. Dicerna Pharmaceuticals Revenue Growth Rate in Chronic Liver Diseases Therapeutics Business (2017-2022)
Figure 74. Endo International Revenue Growth Rate in Chronic Liver Diseases Therapeutics Business (2017-2022)
Figure 75. Provectus Biopharmaceuticals Revenue Growth Rate in Chronic Liver Diseases Therapeutics Business (2017-2022)
Figure 76. MAX BioPharma Revenue Growth Rate in Chronic Liver Diseases Therapeutics Business (2017-2022)
Figure 77. Bottom-up and Top-down Approaches for This Report
Figure 78. Data Triangulation
Figure 79. Key Executives Interviewed
